Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation

CompletedOBSERVATIONAL
Enrollment

161

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

September 4, 2020

Study Completion Date

September 4, 2020

Conditions
Chronic Hepatitis C (CHC)
Trial Locations (9)

190103

Saint-Petersburg AIDS Center /ID# 212380, Saint Petersburg

302038

SIH Orlovskiy region city hospital named after S.P. Botkin /ID# 212383, Oryol

355035

Professor Pasechnikov Gastroenterology and Pankreatology clinic /ID# 217035, Stavropol

420140

A. F. Agafonov Republican Clin /ID# 212381, Kazan'

443063

LLC Medical Company Hepatolog /ID# 212384, Samara

443099

Samara State Medical Universit /ID# 217029, Samara

454052

South Ural State Medical univ /ID# 212020, Chelyabinsk

614000

Perm Regional Center of Cepato /ID# 213992, Perm

630099

Clinical Inf. Dis Hospital 1 /ID# 217033, Novosibirsk

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY